412 related articles for article (PubMed ID: 24328866)
1. Seizure characteristics and prognostic factors of gliomas.
Kerkhof M; Vecht CJ
Epilepsia; 2013 Dec; 54 Suppl 9():12-7. PubMed ID: 24328866
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and treatment of seizures in patients with high-grade glioma: a review.
Englot DJ; Berger MS; Chang EF; Garcia PA
Neurosurg Clin N Am; 2012 Apr; 23(2):227-35, vii-viii. PubMed ID: 22440866
[TBL] [Abstract][Full Text] [Related]
3. Epilepsy-related brain tumors.
Ertürk Çetin Ö; İşler C; Uzan M; Özkara Ç
Seizure; 2017 Jan; 44():93-97. PubMed ID: 28041673
[TBL] [Abstract][Full Text] [Related]
4. Seizure characteristics and control following resection in 332 patients with low-grade gliomas.
Chang EF; Potts MB; Keles GE; Lamborn KR; Chang SM; Barbaro NM; Berger MS
J Neurosurg; 2008 Feb; 108(2):227-35. PubMed ID: 18240916
[TBL] [Abstract][Full Text] [Related]
5. Seizures in low- and high-grade gliomas: current management and future outlook.
Vecht CJ; Wilms EB
Expert Rev Anticancer Ther; 2010 May; 10(5):663-9. PubMed ID: 20469999
[TBL] [Abstract][Full Text] [Related]
6. Seizures in glioma patients: An overview of incidence, etiology, and therapies.
Samudra N; Zacharias T; Plitt A; Lega B; Pan E
J Neurol Sci; 2019 Sep; 404():80-85. PubMed ID: 31352293
[TBL] [Abstract][Full Text] [Related]
7. Epilepsy in primary cerebral tumors: the characteristics of epilepsy at the onset (results from the PERNO study--Project of Emilia Romagna Region on Neuro-Oncology).
Michelucci R; Pasini E; Meletti S; Fallica E; Rizzi R; Florindo I; Chiari A; Monetti C; Cremonini AM; Forlivesi S; Albani F; Baruzzi A;
Epilepsia; 2013 Oct; 54 Suppl 7():86-91. PubMed ID: 24099060
[TBL] [Abstract][Full Text] [Related]
8. Surgical assessment of the insula. Part 2: validation of the Berger-Sanai zone classification system for predicting extent of glioma resection.
Hervey-Jumper SL; Li J; Osorio JA; Lau D; Molinaro AM; Benet A; Berger MS
J Neurosurg; 2016 Feb; 124(2):482-8. PubMed ID: 26339856
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of anti-epileptic drugs in patients with gliomas and seizures.
van Breemen MS; Rijsman RM; Taphoorn MJ; Walchenbach R; Zwinkels H; Vecht CJ
J Neurol; 2009 Sep; 256(9):1519-26. PubMed ID: 19434440
[TBL] [Abstract][Full Text] [Related]
10. Extent of surgical resection predicts seizure freedom in low-grade temporal lobe brain tumors.
Englot DJ; Han SJ; Berger MS; Barbaro NM; Chang EF
Neurosurgery; 2012 Apr; 70(4):921-8; discussion 928. PubMed ID: 21997540
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with seizure freedom in the surgical resection of glioneuronal tumors.
Englot DJ; Berger MS; Barbaro NM; Chang EF
Epilepsia; 2012 Jan; 53(1):51-7. PubMed ID: 21933181
[TBL] [Abstract][Full Text] [Related]
12. Seizures in oligodendroglial tumors.
Kerkhof M; Benit C; Duran-Pena A; Vecht CJ
CNS Oncol; 2015; 4(5):347-56. PubMed ID: 26478444
[TBL] [Abstract][Full Text] [Related]
13. Seizure control following tumor surgery for childhood cortical low-grade gliomas.
Packer RJ; Sutton LN; Patel KM; Duhaime AC; Schiff S; Weinstein SR; Gaillard WD; Conry JA; Schut L
J Neurosurg; 1994 Jun; 80(6):998-1003. PubMed ID: 8189281
[TBL] [Abstract][Full Text] [Related]
14. Ki-67 overexpression in WHO grade II gliomas is associated with poor postoperative seizure control.
Yuan Y; Xiang W; Yanhui L; Ruofei L; Shuang L; Yingjun F; Qiao Z; Yanwu Y; Qing M
Seizure; 2013 Dec; 22(10):877-81. PubMed ID: 23992787
[TBL] [Abstract][Full Text] [Related]
15. Epileptic seizures in diffuse low-grade gliomas in adults.
Pallud J; Audureau E; Blonski M; Sanai N; Bauchet L; Fontaine D; Mandonnet E; Dezamis E; Psimaras D; Guyotat J; Peruzzi P; Page P; Gal B; Párraga E; Baron MH; Vlaicu M; Guillevin R; Devaux B; Duffau H; Taillandier L; Capelle L; Huberfeld G
Brain; 2014 Feb; 137(Pt 2):449-62. PubMed ID: 24374407
[TBL] [Abstract][Full Text] [Related]
16. Epilepsy and gliomas: incidence and treatment in 119 patients.
Pace A; Bove L; Innocenti P; Pietrangeli A; Carapella CM; Oppido P; Raus L; Occhipinti E; Jandolo B
J Exp Clin Cancer Res; 1998 Dec; 17(4):479-82. PubMed ID: 10089071
[TBL] [Abstract][Full Text] [Related]
17. Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments.
Rudà R; Bello L; Duffau H; Soffietti R
Neuro Oncol; 2012 Sep; 14 Suppl 4(Suppl 4):iv55-64. PubMed ID: 23095831
[TBL] [Abstract][Full Text] [Related]
18. Seizures and Anticonvulsants in Brain Tumours: Frequency, Mechanisms and Anti-Epileptic Management.
Vecht C; Royer-Perron L; Houillier C; Huberfeld G
Curr Pharm Des; 2017; 23(42):6464-6487. PubMed ID: 29076421
[TBL] [Abstract][Full Text] [Related]
19. Epilepsy in cerebral glioma: timing of appearance and histological correlations.
Rosati A; Tomassini A; Pollo B; Ambrosi C; Schwarz A; Padovani A; Bonetti B
J Neurooncol; 2009 Jul; 93(3):395-400. PubMed ID: 19183850
[TBL] [Abstract][Full Text] [Related]
20. High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma.
Sørensen MF; Heimisdóttir SB; Sørensen MD; Mellegaard CS; Wohlleben H; Kristensen BW; Beier CP
J Neurooncol; 2018 May; 138(1):49-53. PubMed ID: 29404978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
